Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2018 April;73(2) > Minerva Chirurgica 2018 April;73(2):157-62

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,115


eTOC

 

ORIGINAL ARTICLE  


Minerva Chirurgica 2018 April;73(2):157-62

DOI: 10.23736/S0026-4733.17.07292-3

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Polylactide-caprolactone composite mesh for ventral hernia repair: a prospective, randomized, single-blind controlled trial

Ying-Mo SHEN, Qi LI, Jie CHEN , Li SUN, Fu-Qiang CHEN

Department of Hernia and Abdominal Wall Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China


PDF  


BACKGROUND: Although composite surgical meshes are widely used in laparoscopic repair of ventral hernia, the risk of postoperative complications associated with these type of mesh is relatively high. In this report, we demonstrated the safety as well as the effectiveness of a new composite polypropylene mesh coated with poly L-lactide-co-ε-caprolactone (EasyProsthes™) for the repair of ventral hernia.
METHODS: This study was a randomized, controlled trial designed to compare EasyProsthes composite mesh (EPM) with Parietex™ Composite (PCO) in patients undergoing laparoscopic ventral hernia repair. Hernia recurrence, chronic pain, seroma formation, intestinal fistula or obstruction, wound or abdominal infection, and viscera adhesion were evaluated. 80 patients who needed repair surgery for primary or secondary ventral hernias were enrolled in this study. Patients were divided into two groups: the EPM group (N.=40) and the PCO group (N.=40). Patients completed 12 months of follow-up.
RESULTS: Our results revealed that one patient in the EPM group (2.5%) and two patients in the PCO group (5%) developed mesh-viscera adhesions after surgery (P=1.000). We had no case of intestinal fistulas or obstruction. Seventeen patients in EPM group (42.5%) and 21 in PCO group (52.2%) developed post-surgical seromas in the surgery area (P=0.370). One patient from each group developed postoperative wound infection. There was no case of abdominal infection, chronic pain or hernia recurrence. The incidence of postoperative complications in the EPM group was similar to that observed in the PCO group.
CONCLUSIONS: EPM is a safe and effective method to be used in ventral hernia repair surgeries.


KEY WORDS: Ventral hernia - Herniorrhaphy - Surgical mesh - Poly(lactide)

top of page

Publication History

Issue published online: April 5, 2018
Article first published online: February 23, 2017
Manuscript accepted: February 3, 2017
Manuscript received: January 8, 2017

Cite this article as

Shen YM, Li Q, Chen J, Sun L, Chen FQ. Polylactide-caprolactone composite mesh for ventral hernia repair: a prospective, randomized, single-blind controlled trial. Minerva Chir 2018;73:157-62. DOI: 10.23736/S0026-4733.17.07292-3

Corresponding author e-mail

chenjie20160628@163.com